Frontlight ResearchEarly access
Trial site
Specjalistyczny Niepubliczny Zaklad Opieki Zdrowotnej Alergologia Plus Osrodek Diagnostyki I Terapii Uczulen
- 6running trials
- 9closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Asthma4 trials
- COPD4 trials
- Chronic rhinosinusitis with nasal polyps3 trials
- Atopic dermatitis (eczema)2 trials
- Chronic spontaneous urticaria2 trials
- Phase
- Phase 310 trials
- Phase 24 trials
- Phase 41 trial
- Status
- Completed9 trials
- Active, not recruiting4 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Lead sponsor
- Sanofi4 trials
- Chiesi Farmaceutici S.p.A.3 trials
- AbbVie2 trials
- AstraZeneca2 trials
- Areteia Therapeutics Inc.1 trial
- and 3 more
Running trials
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Chronic spontaneous urticaria1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Completed
Completed
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026